RecruitingNot applicableNCT05057702
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Studying Anaplastic ependymoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of California, San Francisco
- Principal Investigator
- Sabine Mueller, MD, PhD, MAS, MD, PhDUniversity of California, San Francisco
- Intervention
- Specialized Tumor Board Treatment Plan(other)
- Enrollment
- 74 enrolled
- Eligibility
- 39 years · All sexes
- Timeline
- 2022 – 2028
Study locations (8)
- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Rady Children's Hospital, San Diego, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Children's National Hospital, Washington D.C., District of Columbia, United States
- St. Louis Children's Hospital / Washington University in St. Louis, St Louis, Missouri, United States
- New York University, New York, New York, United States
- Columbia University Medical Center, New York, New York, United States
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Collaborators
Washington University School of Medicine · St. Baldrick's Foundation · Ashion Analytics · University of Washington · Pediatric Neuro-Oncology Consortium
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05057702 on ClinicalTrials.govOther trials for Anaplastic ependymoma
Additional recruiting or active studies for the same condition.